Antithrombotic therapy in patients with prosthetic heart valves

Authors

  • Fidel Manuel Cáceres Lóriga Instituto de Cardiología y Cirugía Cardiovascular, Calle 17 # 702, esq A, El Vedado, Ciudad de La Habana, Cuba.
  • Horacio Pérez López
  • Karel Morlans Hernández

Keywords:

HEART VALVE PROSTHESIS, FIBRINOLYTIC AGENTS/therapeutic use, ANTICOAGULANTES/therapeutic use.

Abstract

The thromboembolic events are still an important complication in patients with substitution of any of the heart valves in spite of the advances obtained in the design of prostheses. On reviewing literature, we confirm that the modalities of less intense anticoagulation, with platelet antiaggregant treatment or without it , have been efficient and safe in these patients. The recommended oral anticoagulation therapy for biological protheses should attain an international standardized range from 2,0 to 3,0 and of lower intensity than that previously administered to patients with mechanical prostheses.

Downloads

Download data is not yet available.

Author Biography

Fidel Manuel Cáceres Lóriga, Instituto de Cardiología y Cirugía Cardiovascular, Calle 17 # 702, esq A, El Vedado, Ciudad de La Habana, Cuba.

Especialista de I Grado en Cardiología.

Published

2014-03-20

How to Cite

1.
Cáceres Lóriga FM, Pérez López H, Morlans Hernández K. Antithrombotic therapy in patients with prosthetic heart valves. Rev. cuba. cardiol. cir. cardiovasc. [Internet]. 2014 Mar. 20 [cited 2025 Feb. 11];14(1). Available from: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/472

Issue

Section

Review Article

Most read articles by the same author(s)

1 2 3 > >>